XBIT vs. IBIO

In the year-to-date period, XBIT achieves a -29.87% return, which is significantly higher than IBIO's -68.44% return. Over the past 10 years, XBIT has outperformed IBIO with an annualized return of -17.06%, while IBIO has yielded a comparatively lower -57.80% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and iBio, Inc. (IBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current XBIT Sharpe Ratio is -0.84, which is lower than the IBIO Sharpe Ratio of -0.52. The chart below compares the historical Sharpe Ratios of XBIT and IBIO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither XBIT nor IBIO has paid dividends to shareholders.

The maximum XBIT drawdown since its inception was -92.67%, smaller than the maximum IBIO drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for XBIT and IBIO. For additional features, visit the drawdowns tool.

The current volatility for XBiotech Inc. (XBIT) is 25.41%, while iBio, Inc. (IBIO) has a volatility of 36.69%. This indicates that XBIT experiences smaller price fluctuations and is considered to be less risky than IBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between XBiotech Inc. and iBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.